What you should know about thrombolytic therapy for acute MI.
Aragon
D
D
Orlando Regional Healthcare System, FL.
Martin
M
M
D000465:Algorithms; D016255:Anistreplase / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology; D003325:Coronary Care Units; D003663:Decision Trees; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing; D015425:Myocardial Reperfusion / Q000009:adverse effects; D009730:Nursing Assessment; D010347:Patient Care Planning; D010360:Patient Transfer; D013300:Streptokinase / Q000494:pharmacology / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000379:methods* / Q000451:nursing; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use*; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use*
D016255:Anistreplase; D006493:Heparin; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator